Diseases
Researchers have made significant strides in developing nanomaterial-based stimulus-responsive drug delivery systems (SRDDS) that facilitate precise therapy for hematologic diseases. According to a study published in the Journal of Materials Chemistry B, SRDDS integrate the chemical properties of drugs with the organism's environment and immune response, modulating the
Diseases
Researchers have made a significant breakthrough in understanding Parkinson's disease (PD), detailing two distinct phenotypes that develop before motor symptoms appear. The study, conducted by the Karolinska Institute, highlights the importance of recognizing these phenotypes to develop targeted and personalized therapeutic strategies. Key Takeaways: * The study analyzed 910
Diseases
Researchers at the University of Florida have shed light on the complex role of immune dysregulation in Parkinson's disease, a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. According to a study published in Neuroglia, immune-based interventions may hold therapeutic potential in disease modification. The research highlights
Diseases
Researchers at Qingdao University have made a significant breakthrough in the field of personalized medicine by developing biocompatible and high-performance flexible pressure sensors for Parkinson's disease management. According to the study, the flexible pressure sensors possess considerable potential in facilitating Parkinson's disease rehabilitation, particularly in the
Diseases
Research from the Longgang District Central Hospital of Shenzhen has led to the development of a fully integrated wearable nanosensor that provides a minimally invasive and user-friendly strategy for Alzheimer's disease (AD) screening. This biosensing platform, which incorporates a microneedle-based interstitial fluid (ISF) sampling device and an ultrasensitive
Artificial intelligence
As medical imaging technology continues to advance, researchers are leveraging its potential to bridge the gap between genomic data and clinical practice. Imaging genomics, also known as radiogenomics, has emerged as a promising area of research, aiming to associate clinical image data with human genetic data to better understand the
Machine learning
Researchers at the Department of Medical Laboratory Sciences report that rapid advancements in diagnostic technology are transforming the healthcare industry. According to the research, emerging technologies such as digital biomarkers, artificial intelligence, and the quantified-self movement are altering traditional diagnostic methods. This transformation is ushering in a new era of
Machine learning
Researchers at the University of Cambridge have made significant progress in the field of personalized cancer therapy using artificial intelligence. Their study, published in npj Precision Oncology, explores the concept of employing a function-based profile of cells to identify effective treatment options for patients. The study demonstrates a proof-of-concept approach
Machine learning
Research from the Autonomous University Barcelona (UAB) has emphasized the need for the development of advanced AI techniques in personalized medicine. The increasing demand for personalized medicine requires the accurate characterization of pathological heterogeneity, which is a key factor in disease progression, treatment response, and prognosis. Current machine learning (ML)
Machine learning
Researchers at Wenzhou Medical University, in collaboration with several institutions, have published a new study on personalized medicine, focusing on immunogenic cell death (ICD) and its impact on bladder cancer prognosis and treatment. The study, published in ACS Omega, identified 32 key ICD-risk genes (IRGs) and constructed an ICD-based prognostic
Artificial intelligence
Acclaimed AI researcher Md Habibur Rahman has published a seminal book titled CODE LIFE: How Algorithms Are Reshaping the Future of Healthcare, which explores AI-driven diagnostics, ethical challenges, and the future of personalized medicine in transforming patient outcomes. The book is a culmination of Rahman's pioneering research in
Artificial intelligence
Research conducted by Second People's Hospital in Anhui, People's Republic of China, has demonstrated the feasibility and efficacy of developing a predictive model for postoperative recurrence and metastasis in breast cancer using the Artificial Intelligence Ultrasound Breast System (AIUBS). The study, published in the American Journal
